Equities
  • Price (EUR)52.90
  • Today's Change0.26 / 0.49%
  • Shares traded0.00
  • 1 Year change67.19%
  • Beta--
Data delayed at least 15 minutes, as of Dec 06 2019.
More ▼

Profile data is unavailable for this security.

About the company

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.

  • Revenue in USD (TTM)3.98bn
  • Net income in USD160.70m
  • Incorporated1983
  • Employees16.40k
  • Location
    Dentsply Sirona Inc13320 Ballantyne Corporate PlCHARLOTTE 28277-3607United StatesUSA
  • Phone+1 (717) 845-7511
  • Fax+1 (302) 636-5454
  • Websitehttps://www.dentsplysirona.com/
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.